Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06327152 · ClinicalTrials.gov registry record · Phase 2
Caffeine Use in the Management of Preterm Infants
A Phase 2 study of Apnea of Prematurity, sponsored by University of California, Irvine.
- Active
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06327152: Active Phase 2 study of Apnea of Prematurity, sponsored by University of California, Irvine.
NCT06327152 is a Phase 2 study of Apnea of Prematurity that is active but no longer recruiting, run by University of California, Irvine. The registered enrollment target is 80 participants, below the 395-participant average among 6 other Apnea of Prematurity trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06327152, a Phase 2 study of Apnea of Prematurity, is active but no longer recruiting, sponsored by University of California, Irvine.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to assess whether extending the duration of caffeine therapy will help preterm infants achieve full oral feeding faster.
Primary Outcome
The primary outcome is time (in days) to full oral bottle feeding or breastfeeding or a combination of both. Full oral bottle feeding is defined as 48 hours of consistent intake of at least 150ml/kg/day of formula or breastmilk. If the subject is on combination of bottle and breastfeeding, two consecutive days of positive weight gain will be used in place of 150ml/kg/day as primary outcome measure.
Conditions Studied
Interventions
- DRUG Caffeine
- OTHER Sterile Water Placebo
Study Locations (1)
California
- UC Irvine Medical Center - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-02-22 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 2 |
What the registry record for NCT06327152 still lists
NCT06327152 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 395-participant average among 6 other Apnea of Prematurity trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Apnea of Prematurity appearing as the primary indexed condition, and to 2 interventions - of which Caffeine is the first listed.
NCT06327152 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06327152 about?
NCT06327152 is a clinical study titled "Caffeine Use in the Management of Preterm Infants". This study aims to assess whether extending the duration of caffeine therapy will help preterm infants achieve full oral feeding faster.
What is the current status of trial NCT06327152?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2024-02-22. Estimated completion is 2026-12-31.
What conditions does trial NCT06327152 study?
This clinical trial studies the following conditions: Apnea of Prematurity.
What interventions are being tested in trial NCT06327152?
The interventions under investigation include: Caffeine (DRUG), Sterile Water Placebo (OTHER).
Who is sponsoring clinical trial NCT06327152?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06327152 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Apnea of Prematurity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
RECRUITING · NA
-
"Prapela® SVS Incubator Pad for Apnea of Prematurity
RECRUITING · NA
-
A Comparison of Non-invasive Ventilation Methods Used to Prevent Endotracheal Intubation Due to Apnea in Very Low Birth Weight Infants
COMPLETED · NA
-
Caffeine for Apnea of Prematurity (CAP)
COMPLETED · Phase 3
-
The Effect of Standardizing the Definition of a Clinically Significant Cardiopulmonary Event on Length of Stay
COMPLETED
-
Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI